Regulatory Open Forum

 View Only

Challenges of CMC regulatory submissions for gene therapies

  • 1.  Challenges of CMC regulatory submissions for gene therapies

    Posted 30 days ago

    There’s limited regulatory guidance on gene therapies for many drug manufacturers and how it can be a struggle to develop successful strategies for CMC. 

    At this upcoming RAPS workshop, @Janmeet Anant will provide attendees with a thorough understanding of extrapolating current regulatory guidance on sterile injectable aseptic processing for gene therapies and much more. 

    We hope to see you there. Click here to save your seat today. 



    ------------------------------
    Brooke Keith
    Marketing
    Denver CO
    United States
    ------------------------------